Addressing the role of edaravone in the management of amyotrophic lateral sclerosis and gaps in care and access: Expert panel recommendations

Christina J. Barrington; Martin Burruano; Caroline Carney; Joseph Choi; Jeff Januska; Lester Lachuk; Björn Oskarsson; Carly Rodriguez; Lindsay Speicher; Gary Tereso

doi:10.37765/AJMC.2021.88732

Addressing the role of edaravone in the management of amyotrophic lateral sclerosis and gaps in care and access: Expert panel recommendations

Christina J. Barrington, Martin Burruano, Caroline Carney, Joseph Choi, Jeff Januska, Lester Lachuk, Björn Oskarsson, Carly Rodriguez, Lindsay Speicher, Gary Tereso

Neurology

Research output: Contribution to journal › Article › peer-review

Abstract

A virtual key opinion leader (KOL) and payer discussion was held on December 5, 2020. In attendance were 2 KOLs, both specialists in amyotrophic lateral sclerosis (ALS) at leading clinics in the United States, and 6 managed care executives from US regional health plans. The objective of this panel was to share opinions, ideas, and information around the treatment of ALS with edaravone, gaps in management and guidelines, and potential solutions. The panel concluded that coverage criteria for edaravone may need to be reassessed and treatment guidelines could be revisited to include a determination of place in therapy for edaravone.

Original language	English (US)
Pages (from-to)	S231-S237
Journal	American Journal of Managed Care
Volume	27
Issue number	12
DOIs	https://doi.org/10.37765/AJMC.2021.88732
State	Published - Aug 2021

ASJC Scopus subject areas

Health Policy

Access to Document

10.37765/AJMC.2021.88732

Cite this

Barrington, C. J., Burruano, M., Carney, C., Choi, J., Januska, J., Lachuk, L., Oskarsson, B., Rodriguez, C., Speicher, L., & Tereso, G. (2021). Addressing the role of edaravone in the management of amyotrophic lateral sclerosis and gaps in care and access: Expert panel recommendations. American Journal of Managed Care, 27(12), S231-S237. https://doi.org/10.37765/AJMC.2021.88732

Barrington, CJ, Burruano, M, Carney, C, Choi, J, Januska, J, Lachuk, L, Oskarsson, B, Rodriguez, C, Speicher, L & Tereso, G 2021, 'Addressing the role of edaravone in the management of amyotrophic lateral sclerosis and gaps in care and access: Expert panel recommendations', American Journal of Managed Care, vol. 27, no. 12, pp. S231-S237. https://doi.org/10.37765/AJMC.2021.88732

@article{55e28bc5da7b4f818e4df23c1d77d9f3,

title = "Addressing the role of edaravone in the management of amyotrophic lateral sclerosis and gaps in care and access: Expert panel recommendations",

abstract = "A virtual key opinion leader (KOL) and payer discussion was held on December 5, 2020. In attendance were 2 KOLs, both specialists in amyotrophic lateral sclerosis (ALS) at leading clinics in the United States, and 6 managed care executives from US regional health plans. The objective of this panel was to share opinions, ideas, and information around the treatment of ALS with edaravone, gaps in management and guidelines, and potential solutions. The panel concluded that coverage criteria for edaravone may need to be reassessed and treatment guidelines could be revisited to include a determination of place in therapy for edaravone.",

author = "Barrington, {Christina J.} and Martin Burruano and Caroline Carney and Joseph Choi and Jeff Januska and Lester Lachuk and Bj{\"o}rn Oskarsson and Carly Rodriguez and Lindsay Speicher and Gary Tereso",

year = "2021",

month = aug,

doi = "10.37765/AJMC.2021.88732",

language = "English (US)",

volume = "27",

pages = "S231--S237",

journal = "American Journal of Managed Care",

issn = "1088-0224",

publisher = "Ascend Media",

number = "12",

}

TY - JOUR

T1 - Addressing the role of edaravone in the management of amyotrophic lateral sclerosis and gaps in care and access

T2 - Expert panel recommendations

AU - Barrington, Christina J.

AU - Burruano, Martin

AU - Carney, Caroline

AU - Choi, Joseph

AU - Januska, Jeff

AU - Lachuk, Lester

AU - Oskarsson, Björn

AU - Rodriguez, Carly

AU - Speicher, Lindsay

AU - Tereso, Gary

PY - 2021/8

Y1 - 2021/8

N2 - A virtual key opinion leader (KOL) and payer discussion was held on December 5, 2020. In attendance were 2 KOLs, both specialists in amyotrophic lateral sclerosis (ALS) at leading clinics in the United States, and 6 managed care executives from US regional health plans. The objective of this panel was to share opinions, ideas, and information around the treatment of ALS with edaravone, gaps in management and guidelines, and potential solutions. The panel concluded that coverage criteria for edaravone may need to be reassessed and treatment guidelines could be revisited to include a determination of place in therapy for edaravone.

AB - A virtual key opinion leader (KOL) and payer discussion was held on December 5, 2020. In attendance were 2 KOLs, both specialists in amyotrophic lateral sclerosis (ALS) at leading clinics in the United States, and 6 managed care executives from US regional health plans. The objective of this panel was to share opinions, ideas, and information around the treatment of ALS with edaravone, gaps in management and guidelines, and potential solutions. The panel concluded that coverage criteria for edaravone may need to be reassessed and treatment guidelines could be revisited to include a determination of place in therapy for edaravone.

UR - http://www.scopus.com/inward/record.url?scp=85113882870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85113882870&partnerID=8YFLogxK

U2 - 10.37765/AJMC.2021.88732

DO - 10.37765/AJMC.2021.88732

M3 - Article

C2 - 34382759

AN - SCOPUS:85113882870

SN - 1088-0224

VL - 27

SP - S231-S237

JO - American Journal of Managed Care

JF - American Journal of Managed Care

IS - 12

ER -

Addressing the role of edaravone in the management of amyotrophic lateral sclerosis and gaps in care and access: Expert panel recommendations

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this